[1] Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system[J]. Nat Rev Immunol, 2014, 14(6): 405–416.
[2] Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome[J]. J Bacteriol, 2010, 192(19): 5002–5017.
[3] Chen T, Yu WH, Izard J, et al. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information[J]. Database (Oxford), 2010, 2010: baq013.
[4] Ghannoum MA, Jurevic RJ, Mukherjee PK, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals[J]. PLoS Pathog, 2010, 6(1): e1000713.
[5] Mukherjee PK, Chandra J, Retuerto M, et al. Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi[J]. PLoS Pathog, 2014, 10(3): e1003996.
[6] Suárez BL, Álvarez MI, de Bernal M, et al. Candida species and other yeasts in the oral cavities of type 2 diabetic patients in Cali, Colombia[J]. Colomb Méd, 2013, 44(1): 26–30.
[7] Padilla APP. Prevalencia de lesiones en cavidad oral en pacientes con VIH /Sida en HERES Salud E.U. de la ciudad de Santa Marta en el periodo 2006-2007. Universidad Nacional de Colombia. 2011[EB/OL]. http://www.bdigital.unal.edu.co/7000/1/597683.2011.pdf.
[8] Becerra NEM, Figueroa MMB, Schanowsky FAB, et al. Frecuencia de lesiones en cavidad oral de pacientes con VIH/sida en el Hospital Universitario San Ignacio de Bogotá, Colombia (2005-2010)[J]. Univ Odontol, 2012, 31(66): 51–58.
[9] Ricardo JH, Cobos MR, Caballero AJD. Oral lesions in patients with HIV/AIDS associated with antiretroviral therapy and viral load[J]. Salud Uninorte, 2012, 28(3): 373–381.
[10] Minsalud. Ⅳ estudio nacional de salud bucal. ENSAB Ⅳ[R]. Bogotá: Ministerio de Salud y Protección Social, 2014: 381.
[11] White TJ, Bruns S, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics[M]//Innis MA, Gelfand DH, Sninsky JJ, et al. PCR Protocols: A Guide to Methods and Applications. Amsterdam: Elsevier, 1990: 315−322.
[12] Sullivan DJ, Moran GP, Pinjon E, et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans[J]. FEMS Yeast Res, 2004, 4(4-5): 369–376.
[13] Sneath PHA, Sokal RR. Numerical taxonomy: the principles and practice of numerical classification[M]. San Francisco: W. H. Freeman, 1973: 263−268.
[14] Felsenstein J. Confidence limits on phylogenies : an approach using the bootstrap[J]. Evolution, 1985, 39(4): 783–791.
[15] Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method[J]. Proc Natl Acad Sci USA, 2004, 101(30): 11030–11035.
[16] Di Rienzo JA, Casanoves F, Balzarini MG, et al. InfoStat versión 2010[R]. Argentina: Grupo InfoStat FCA, Universidad Nacional de Córdoba, 2010.
[17] Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of america[J]. Clin Infect Dis, 2016, 62(4): e1–e50.
[18] Muzyka BC, Epifanio RN. Update on oral fungal infections[J]. Dent Clin North Am, 2013, 57(4): 561–581.
[19] Xu JP, Mitchell TG. Geographical differences in human oral yeast flora[J]. Clin Infect Dis, 2003, 36(2): 221–224.
[20] Cavaleiro I, Proença L, Félix S, et al. Prevalence of yeast other than Candida albicans in denture wearers[J]. J Prosthodont, 2013, 22(5): 351–357.
[21] Silva S, Henriques M, Hayes A, et al. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium[J]. J Oral Pathol Med, 2011, 40(5): 421–427.
[22] Pathak AK, Sharma S, Shrivastva P. Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate[J]. J Appl Oral Sci, 2012, 20(1): 70–75.
[23] Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies[J]. Cell Microbiol, 2013, 15(5): 701–708.
[24] Nejad BS, Rafiei A, Moosanejad F. Prevalence of Candida species in the oral cavity of patients with periodentitis[J]. Afr J Biotechnol, 2013, 10(15): 2987–2990.
[25] Rossoni RD, Barbosa JO, Vilela SFG, et al. Competitive interactions between C. albicans, C. glabrata and C. krusei during Biofilm formation and development of experimental candidiasis[J]. PLoS One, 2015, 10(7): e0131700.
[26] Darwazeh AMG, Darwazeh TA. What makes oral candidiasis recurrent infection? a clinical view[J]. J Mycol, 2014, 2014: 758394.